Abstract. We have developed a laser ablation sampling technique for matrix-assisted laser desorption ionization (MALDI) mass spectrometry and tandem mass spectrometry (MS/MS) analyses of in-situ digested tissue proteins. Infrared laser ablation was used to remove biomolecules from tissue sections for collection by vacuum capture and analysis by MALDI. Ablation and transfer of compounds from tissue removes biomolecules from the tissue and allows further analysis of the collected material to facilitate their identification. Laser ablated material was captured in a vacuum aspirated pipette-tip packed with C18 stationary phase and the captured material was dissolved, eluted, and analyzed by MALDI. Rat brain and lung tissue sections 10 μm thick were processed by in-situ trypsin digestion after lipid and salt removal. The tryptic peptides were ablated with a focused mid-infrared laser, vacuum captured, and eluted with an acetonitrile/ water mixture. Eluted components were deposited on a MALDI target and mixed with matrix for mass spectrometry analysis. Initial experiments were conducted with peptide and protein standards for evaluation of transfer efficiency: a transfer efficiency of 16% was obtained using seven different standards. Laser ablation vacuum capture was applied to freshly digested tissue sections and compared with sections processed with conventional MALDI imaging. A greater signal intensity and lower background was observed in comparison with the conventional MALDI analysis. Tandem time-of-flight MALDI mass spectrometry was used for compound identification in the tissue.
Introduction

S
ince its introduction in 1985 by Hillenkamp et al [1] , matrix-assisted laser desorption ionization (MALDI) has experienced rapid growth in life science and medicine [2] . An important component of the success of this technique has been MALDI mass spectrometry imaging (MSI) of tissue sections, which was introduced in 1997 by Caprioli and coworkers [3] . Over the years, MALDI and MSI have emerged as powerful tools for investigating the identity and location of biomolecules in tissue samples and have been extensively employed in biological and in clinical studies [4] [5] [6] [7] . Optimization of both techniques has been conducted with a focus on improving the spatial localization and identification of the detected biomolecules. Although improvements in instrument design have brought MALDI imaging increasingly toward single-cell analysis [8] , compound identification remains one of the biggest challenges. Identification of compounds produced during a MALDI or MSI experiments is made difficult by the mass of the analyte, which may preclude MS/MS as in the case of proteins, its concentration, or by the presence of multiple isobaric signals with the consequent lack of unambiguous identification of important biomolecules such as peptides and proteins [9, 10] . This leads to a number of published MSI experiments in which compound identification is not possible, in contrast to the increasing number of LC-MS/MS-based works published to date [11] .
Compound identification in MALDI mass spectrometry imaging can be achieved in bulk by analyzing serial tissue sections with LC-MS/MS techniques after whole tissue homogenization, protein extraction and fractionation, and insolution digestion [12, 13] . Nevertheless, correlation of the LC-MS/MS identified molecules to intact proteins and peptides detected with MALDI is often difficult [14] . LC-MS has been coupled with in-situ digestion MALDI imaging, where enzymatic processing of the protein material can be conducted directly on the tissue prior to matrix deposition [15] . Although this approach has improved the identification of localized proteins, only few proteins can be identified, and parallel
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Localized tissue regions of interest can be selected using laser capture microdissection (LCM) [17] . Direct MALDI mass spectrometry of the dissected material has been used to determine molecular features in pathologically identified region of interests [18] [19] [20] . For an in-depth mass spectrometry analysis, the microdissected tissue is further processed to extract analytes of interest such as proteins [21] . Recently, Hebbar and coworkers demonstrated direct collection of material isolated with a LCM instrument on a C18 chromatographic cartridge for lipid analysis from 50 cells [22] . Direct coupling of an LCM system with a mass spectrometry interface has also been reported [23] . Here, a 349 nm Nd:YLF laser with 5 kHz repetition rate and 120 μJ pulse energy was used to ablate material that was ionized in an APCI source. The system was used to acquire mass spectrometry images of lipids from mouse brain tissue with a spatial resolution of 10 μm.
Additional localization of material can be achieved using liquid microjunction (LMJ) extraction [24, 25] . Unlike LCM, extraction methods do not require tissue lysis. Recently, Quanico and co-workers developed a liquid extraction method for analysis of specific regions on rat brain tissue sections; the results were then correlated with MSI experiments conducted on in-situ digested serial sections [26] . Because of the common digestion step, correlation of the LC-MS/MS and MALDI data was improved, although more than 30% of the detected MALDI peaks remained unassigned. Therefore, improving the MALDI identification capabilities of in situ digested peptides is expected to lead to better compound identification.
Analyte extraction by laser ablation can provide better localization and faster scanning as well as eliminate direct contact of extraction solvent with the tissue. We have recently used the technique of laser ablation sample transfer (LAST) in conjunction with MSI for the analysis of lipids in rat brain tissue sections [27] . Laser ablation sample transfer using UV and IR lasers has been coupled with liquid capture and mass spectrometry, displaying the ability to transfer and detect large biomolecules [28, 29] . In particular, IR lasers have been used in several studies [30] [31] [32] because of their high material removal efficiency.
In the work described below, laser ablation sample transfer was used to analyze in situ digested tryptic peptides from tissue sections. A 3 μm wavelength IR laser was used to ablate material from samples in reflection geometry. The ablated sample was captured by vacuum aspiration near the ablation spot to collect the material in the expanding plume on C18 stationary phase material. The system was used to transfer biomolecules with sizes ranging from peptides to small proteins. The performance of laser ablation vacuum capture was evaluated using molecular weight standards and rat tissue sections with tryptic peptides generated in-situ. Investigation of the optimum laser energy for transfer as well as the conditions for optimum recovery of the captured material was conducted.
Experimental
Chemicals and Biological Samples
Neurotensin, insulin, cytochrome c, trypsin, bradykinin fragment 1-7, bradykinin fragment 2-9, adrenocorticotropic hormone (ACTH) fragment 18- 
Sample Preparation
Stock solutions of peptides and proteins at 1 mM concentration were produced in water unless otherwise indicated. Dilutions were made as required with the same solvent. Initial experiments were performed by spiking 0.2 to 1 μL of solution at the desired concentration on a glass microscope slide (VWR, West Chester, PA, USA). Sample deposits were dried at room temperature before analysis.
Tissue samples were obtained from 4-6 wk old breeding rats at the LSU School of Veterinary Medicine Division of Laboratory Animal Medicine (DLAM). Animals were sacrificed by CO 2 (5 psi) exposure for 1 h. Brain and lung samples were collected and frozen with liquid nitrogen within 30 min. Frozen samples were stored at -80°C. Thin sections were prepared with a Leica CM1850 cryostat (Leica Microsystems, Wetzlar, Germany) directly from the frozen tissue. Optimal cutting temperature (OCT) solution was used to fix one side of the sample to the cryostat support. Particular care was taken to avoid any contact of the OCT solution with the exposed side of the tissue. Coronal rat brain sections were cut at a thickness between 5 and 10 μm whereas rat lung sections were cut to a thickness between 10 and 20 μm. All sections were mounted on uncoated microscope slides or indium tin oxide (ITO) slides and stored at -80°C.
Tissue sample preparation and in-situ digestion was adapted from Franck and co-workers. [33] . Briefly, serial washings were performed with 70% ethanol, 95% ethanol, and chloroform in sequence to remove lipids and salts [26] . Slides were vacuum dried for 10 min before enzyme deposition. Lyophilized trypsin was reconstituted using a 50 mM ammonium bicarbonate solution at pH 7.4. Aliquots with concentrations of 0.2 mg/mL and 1 mg/mL were prepared. A volume of 0.2 μL of trypsin solution at the desired concentration was spiked on several spots. The slide was placed on a metal support in a plastic Petri dish. Two sheets of filter paper wetted with a 1:1 methanol:water solution were placed at the bottom of a covered Petri dish to maintain a saturated humidity environment and avoid evaporation of the droplets. The chamber was placed in a ventilated oven and incubated for 30 min at 37°C. The deposition and incubation step was repeated three times. After digestion, sample slides were immediately processed further or stored at -20°C for a maximum of 3 d.
MALDI matrix solutions were prepared before each set of experiments. A CHCA solution was prepared at a concentration of 10 mg/mL in 1:1 methanol and 0.1% aqueous TFA (v/v). The SA solution was prepared at the same concentration in 3:7 ACN and 0.1% aqueous TFA (v/v).
For direct MALDI tissue analysis, ITO slides were employed. After digestion on the tissue, the section was sprayed with CHCA matrix solution with an in-house built nebulizer employing compressed air at 10 psi and a liquid flow rate of 100 μL/ min. Matrix was sprayed and allowed to dry in multiple cycles. A total of 500 μL was sufficient to deposit a uniform layer on a rat brain tissue section, whereas rat lung section required 750 μL.
Laser Ablation Vacuum Capture
Microscope slides were mounted on a two-axis translation stage (M-433; Newport, Irvine, CA, USA) operated using 50 mm actuators (LTA-HS, Newport) and a motion controller (ESP3000, Newport). The mid-IR laser system used for ablation has been described previously [34] . Briefly, sample slides were irradiated in reflection geometry with a wavelength tunable pulsed IR optical parametric oscillator (IR Opolette; OPOTEK, Carlsbad, CA, USA). The beam was directed onto the sample at a 90°angle and focused with a 50 mm focal length lens. The laser pulse width was 5 ns and the repetition rate was 20 Hz. The wavelength was set at 2.94 μm to overlap with the OH stretch absorption and facilitate comparison with previous studies [35] . A PEEK tube (50 mm length, 1 mm i.d.) was placed~2 mm from above the ablation spot and slightly to the side to avoid interference with the beam path. The tube was kept at an angle between 45°and 60°from normal to the target surface. The open end of a micropipette tip packed with 0.2 μL bed volume of C18 stationary phase material was mounted at the end of the PEEK tube and vacuum was applied to the narrow end of the pipette tip. Rough vacuum (10 -3 torr) was provided by a two-stage dry scroll pump. The laser diameter was approximately 130 μm. Experiments were conducted with fluences between 1 and 50 kJ/m 2 . The laser was attenuated internally using laser control software, and no external attenuation elements were used.
A square raster pattern was used to ablate regions of the sample at a stage velocity of 100 μm/s. Upon completion of the ablation process, the tip was removed and a 10 μL volume of Solvent A (1:1 ACN:0.1% TFA) was drawn into the tip, and a dwell time of 30 s was used to dissolve the captured material. The eluate was collected in a 300 μL tube and nine additional pipetting cycles were employed to ensure complete elution of the material from the tip. The procedure was repeated with Solvent B (1000:1 ACN: 0.1% TFA). The two volumes were combined and 1 μL was spotted on a MALDI target for MS analysis. In the case of tissue analysis, transferred samples were processed as described above but the combined volume was dried under vacuum at room temperature and reconstituted in 3 μL of 1:1 ACN and 0.1% aqueous TFA and deposited on the MALDI target. For standards and captured samples deposited on the MALDI target, the dried droplet method was employed. For the transfer efficiency experiment, the two eluates were combined and further diluted 5-fold with a 0.1% formic acid solution before analysis.
Mass Spectrometry
MALDI MS and MS/MS spectra were acquired using a MALDI-TOF/TOF mass spectrometer (Ultraflextreme; Bruker Daltonics, Billerica, MA, USA). Each spectrum was produced using 250 shots at 500 Hz in partial sample random walk mode, which allows the selection a of position on the target well and sums the spectra from randomly chosen spots over an area of 0.05 mm 2 . A total of 10 spots and 25 shots per spot were selected to build the final spectrum. After activation of the LIFT unit of the instrument [36] , MS/MS spectra were acquired with a 30% higher laser energy. Three MS/MS spectra were acquired with the same partial sample random walk settings as the MS acquisition. These spectra were further summed to build the final spectrum.
ESI-MS chromatograms were recorded using a Bruker Amazon Speed ETD ion trap equipped with a Dionex Ultimate 3000 RSLC UPLC system. A volume of 2 μL was injected in flow-through mode at a flow of 200 μL/ min using a 20:80, 0.1% FA:ACN isocratic mixture. The capillary voltage was 4500 V with an offset of 500 V on the inlet. Scan speed was 32,000 u/s with a resolution of 0.1 mass unit. Ion accumulation was 300,000 ions and 200 ms maximum time. A total of 10 spectra were averaged to generate each single MS spectrum.
Data Analysis
MALDI spectra evaluation was conducted using FlexAnalysis 3.0 software (Bruker). Peak identification was performed in centroid mode and peaks with signal to noise below 3 were not considered. ESI-MS data were analyzed with Data Analysis 4.2 (Bruker). Integration of extracted ion chromatograms was performed manually. BioTools 3.2 software (Bruker) was used for MASCOT MS/MS database searching. MS searches were conducted using both MASCOT and Protein Prospector [37] with a mass tolerance of 0.1 Da. MS/MS searches were conducted with a precursor ion tolerance of 0.2 Da and a fragment tolerance of 0.8 Da. No fixed modification was selected while random methionine oxidation was the only variable modification allowed to include artifact mass shifts [38] . Trypsin missed cleavages were set to two.
For plotting, spectra were processed with in-house software (LabView, National Instruments). Datasets were de-noised with a discrete wavelet transform and the baseline was corrected using a B-spline fit. Finally, data points were reduced to 2500 by averaging. For all spectra, the y axis indicates the maximum intensity (in arbitrary units) recorded with the MALDI instrument.
Results and Discussion
Initial studies were performed using peptide and protein standards. Multiple spots were deposited on a microscope slide from a volume of 0.5 μL of a 1 mM solution of neurotensin for each spot. The dried spots were ablated in turn using a set of fluences from 1 to 50 kJ/m 2 with the repetition rate (20 Hz) and stage velocity (100 μm/s) constant. Complete ablation of the spots was achieved at fluences of 6 kJ/m 2 . This fluence was also used to ablate dried spots containing insulin and cytochrome c. The ablated material was captured in a pipette tip and deposited on a MALDI target with the matrix. No fragmentation was detected for any of the tested analytes. Mass spectra of standards obtained using laser ablation vacuum capture were in all cases comparable to those standards directly deposited on the MALDI target. The extraction step was repeated using tips employed for capture and elution to evaluate carryover effects. At the concentration tested, all of the tips eluted detectable traces of their respective analytes. For the tissue capture experiments described below, the tips were not reused.
Our previous approaches based on laser ablation transfer to solvents were characterized by moderate transfer efficiency. Plume capture performed in a droplet held above the ablation spot resulted in an estimated sample recovery of 1% [34] , whereas capture performed in transmission geometry in a solvent stream achieved an estimated efficiency of 2% [28] . In a work by Ovchinnikova and coworkers [39] , laser ablation in transmission mode using a 355 nm UV laser with the plume was captured in a liquid microjunction resulted in a transfer efficiency of 10%. The use of a vortex probe instead of a liquid microjunction improved this value to 24% [29] using a commercial dye standard.
To evaluate the transfer efficiency of the present approach, a solution containing seven peptides (bradykinin fragment 1-7, bradykinin fragment 2-9, ACTH fragment 18-39, angiotensin II, LHRH, [Glu 1 ]-fibrinopeptide B, and neurotensin), each at a concentration of 1 μM, was prepared and 1 μL aliquots were deposited on 5 spots on an ITO coated microscope slide. Each spot was ablated, captured, extracted, and deposited on a MALDI target. For each MALDI target spot, a spectrum was acquired from 10 positions for a total of 50 spectra per peptide. The intensities of each of the peptide peaks were averaged. For the control experiment, the peptide standard solution was applied directly to the MALDI target and the average protonated molecule intensity was obtained. Table 1 summarizes the results obtained. Defining the transfer efficiency as the ratio of the average intensity of the captured analyte divided by the intensity of the directly deposited analyte, we obtained an average transfer efficiency of 11% (±8). The MALDI approach was characterized by a high variability in recovery, especially in the case of bradykinin fragment 1-7 and angiotensin II, indicative of the limitations of MALDI with regard to quantification [40] . The capture efficiency experiments were repeated using an ion trap mass spectrometer equipped with a commercial electrospray ionization source. A solution containing the same peptides used in the previous experiment was prepared and 1 μL aliquots were deposited on plain microscope slides. The experiment was repeated three times, and each spot was ablated, captured, eluted, and analyzed with ESI-MS. Each sample was injected three times for a total of nine runs. The extracted ion chromatogram of each peptide was integrated and the nine areas obtained were averaged. Control samples were produced by injecting a solution three times at a nominal concentration equal to the theoretical 100% transfer efficiency. As shown in Table 1 , an average transfer efficiency of 16% ± 3% was obtained with efficiencies generally falling in the range of 10% to 20%. No obvious relationship was found between the transfer efficiency and peptide properties such as amino acid composition or compound hydrophobicity. The measured transfer efficiency of 16% is consistent with previous estimates between 10% and 20% [29, 39] but higher than our previously reported values, suggesting improvement in capture efficiency because of the vacuum.
To evaluate the performance of vacuum capture with tissue samples, in-situ digestion was performed with 10 μm-thick rat brain tissue sections. The digestion procedure was adapted from Franck and coworkers [33] with 200 nL of 200 μg/mL trypsin applied to each spot and digested for 1 h. The procedure was repeated three times at each position. This allowed for an efficient and reproducible digestion in a short amount of time with a digested area of about 3 mm 2 . Similar performance was observed at a trypsin concentration of 1 mg/mL and an incubation time of 30 min per cycle.
In this study, the effect of laser fluence and MALDI signal intensity was investigated directly on in-situ digested tissue samples. Optimum signal was obtained at fluences between 6 and 15 kJ/m 2 , whereas ablation conducted outside of this range resulted in nearly no signal. At IR laser fluences greater than 15 kJ/m 2 , the tissue was completely ablated. The presence of a lower energy threshold is consistent with the previous finding on thin insulin film IR ablation [41] . The loss of signal at high fluence can be explained either by large particle production or by thermal degradation of the biomolecules. Large particles can lead to a less efficient extraction during the elution steps, thus explaining the loss of signal. Alternatively, the high fluence could lead to degradation of the ablated material. The thermal degradation hypothesis is consistent with previous experiments on particle size of laser ablated material [42] , where it was found that even at high energy fluences a significant fraction of the ablated material is in the form of small particles. Figure 2a shows a representative mass spectrum of a rat brain tissue section subjected to on-target digestion and direct MALDI analysis. Figure 2b shows a mass spectrum of a tissue section subjected to on-target digestion, laser ablation, vacuum capture, elution, and MALDI analysis of the eluate. In this experiment, two consecutively microtomed tissue sections were mounted on the same slide and digested at the same time. Laser ablation vacuum capture was performed on one of the sections and MALDI was performed on the other section. The area covered by the trypsin droplet is approximately 3 mm 2 , whereas the area of a MALDI target well is 7 mm 2 . The two spectra show comparable signal intensities, with the captured sample spectrum characterized by less noise and smoother baseline. Most of the peaks were assigned to myelin, tubulin, and hemoglobin protein families after a MASCOT search, with the presence of a small number of trypsin autolysis peptides. The captured sample has fewer peaks in the lower m/z region of the spectrum, whereas in the higher m/z region it displays peaks that could not be detected in any of the spots directly analyzed with MALDI.
In the direct MALDI analysis of trypsin-digested spots on rat brain tissue samples, spectra were often obtained with low intensity, few peaks, or the absence of commonly observed peaks from myelin or hemoglobin peptides. In comparison, the vacuum captured samples yielded more reproducible results. A crucial step in any MALDI imaging experiment is the deposition of the matrix, which must penetrate the tissue, extract the analyte, and co-crystalize [43] . The deposition method Figure 2 . MALDI mass spectra of rat brain tissue tryptic peptides with and without capture: (a) trypsin digested spot was sprayed with CHCA matrix and directly analyzed; (b) trypsin digested spot was ablated at a fluence of 6 kJ/m 2 over an area of 4 mm employed in the direct tissue MALDI analysis is commonly used in many MSI experiments. We hypothesize that the reproducibility of the signal in vacuum capture is due to the ability of the matrix and analyte to better co-crystallize when removed from the tissue and deposited on the target. To confirm this hypothesis, laser ablation was performed on spots that did not yield a satisfactory analysis by direct MALDI. Figure 3 shows representative spectra from this set of experiments. Spectra were obtained from a single tissue section and analyzed first by direct MALDI and then, on an adjacent spot of the same tissue section, with ablation capture. The aim was to minimize the variation associated with tissue sample preparation and digestion. Despite the fact that the tissue spot did not produce satisfactory direct MALDI mass spectra, higher signal intensities were recorded after vacuum capture. Figure 3a has several peaks that could not be positively matched to database proteins both with MS and MS/MS searches. Moreover (as in Figure 2a ) the higher m/z region of the spectrum has few peaks. On the other hand, Figure 3b is characterized by peaks corresponding to two of the four identified myelin peaks (at m/z 1460.7 and 1800.8) as the most intense peaks. In addition, the higher m/z region possesses several peaks that were not detected with direct MALDI analysis. At the same time, most of the peaks detected in Figure 3b were detected at lower intensity or not detected in Figure 3a . Sensitivity gain in tissue analysis by mass spectrometry is a major topic of interest for improvement of technologies such as MALDI imaging [4, 44, 45] . This experiment demonstrates that vacuum capture enables a more sensitive detection compared with direct MALDI analysis.
As a further test of laser ablation vacuum capture, experiments were performed on rat lung tissue. Experiments with different laser fluences resulted in the same range of optimum fluence as with the brain tissue: between 6 and 15 kJ/m 2 with significantly lower signal either above or below these values. As with the above experiments, spots were digested on two consecutive tissue sections mounted on the same microscope slide. Upon digestion, one section was sprayed with a saturated CHCA solution whereas the other was processed with laser ablation and vacuum capture. Figure 4a shows a representative mass spectrum of peptides obtained from in-situ digested rat lung tissue directly analyzed with MALDI, whereas Figure 4b shows a representative spectrum of tryptic peptides obtained after ablation and vacuum capture of a spot on the adjacent section. The mass spectra obtained using laser ablation vacuum capture of the digested peptides had consistently higher signal intensity and many peaks that could not be detected by direct MALDI analysis. The experiment on lung tissue adds further evidence that laser ablation vacuum capture can effectively decrease the detection limit of peptides from in-situ digested tissue. The high signal and low noise of the laser ablation vacuum capture mass spectra facilitated the acquisition of tandem timeof-flight mass spectra. Figure 5a shows a MS/MS spectrum for the peptide in Figure 3b at m/z 1460.7. This peak was assigned to myelin basic protein tryptic peptide with sequence TQDENPVVHFFK (residues 211-222) and this finding was confirmed with an MS/MS database search, which yielded a MASCOT score of 80 and over 90% of the peptide backbone identified based on b and y fragments, exceeding previously reported results [46] . Figure 5b shows the tandem mass spectrum of the m/z 1791.0 peptide. The MS/MS spectrum displays a large number of peaks, the majority of which can be assigned to b and y fragment ions of the peptide SYELPDGQVITIGNER with a MASCOT score of 58. The peptide backbone identification exceeded 80%; however, the peptide could not be assigned to a unique protein because the sequence is shared among several members of the actin family.
A comparison of tandem time of flight mass spectrometry of trypsin-digested tissue by direct MALDI analysis and by laser ablation vacuum capture was performed. Figure 6 shows representative spectra of the hemoglobin subunit beta peptide with sequence LLVVYPWTQR [47, 48] . Figure 6a was obtained by direct MALDI MS/MS analysis of digested rat brain tissue spot and Figure 6b was obtained by laser ablation vacuum capture of material from a separate spot on the same tissue section. Although the peak intensities are comparable, the noise is significantly lower in the laser ablation vacuum capture spectrum where the relative intensity of the identified fragments is much higher in comparison to unidentified signals. A Protein Prospector search using the SwissProt database (ver. 6.27.2013) and rodent as the taxonomy matched 20 of the theoretical peptide fragments (four of which are main sequence ions) but hemoglobin subunit beta was ranked second with an ion score of 17.9, whereas a false positive with sequence ISIQKLSNESR (theoretical [M + H] + = 1274.7) was ranked first with a score of 19.1. A search with identical parameters was also performed for Figure 6b . The hemoglobin peptide ranked first with a score of 27.0 and 23 matched peptide backbone fragments. The difference in score observed is not due to a higher number of fragments identified (20 fragments for the direct MALDI sample and 23 for the LAST vacuum captured sample) but to a much lower background in the captured sample spectrum, which results in fewer spurious signals selected for database search and a less ambiguous identification. Moreover, the captured samples are not affected by the presence of the undigested tissue, which most likely causes ion suppression that is often observed in MSI experiments [49] , suggesting that MALDI and MSI can greatly benefit from a separation step [50] .
Conclusions
Application of laser ablation coupled to vacuum capture was demonstrated for mass spectrometry analysis of in-situ digested rat tissue sections. The transfer efficiency was found to be 16% for a range of peptides and proteins. Sample processing was conducted on freshly digested tissue sections as well as on sections previously subjected to direct MALDI analysis. Tandem mass spectrometry database identification was combined with laser ablation vacuum capture and provided a MALDI spectrum with significantly higher signal to noise in comparison to direct MALDI analysis of tissue. The laser ablation vacuum capture approach does not require tissue lysis and extraction steps as does laser capture microdissection, and does not require solvent in contact with the tissue as does liquid microjunction extraction.
Future work will be directed on improving the spatial resolution and coupling with LC-MS/MS analysis. Laser ablation vacuum capture will be used in conjunction with conventional MSI. We anticipate that the addition of separations and tandem mass spectrometry targeted proteomics to the MALDI MSI workflow will significantly improve the ability to identify compounds imaged by that technique and will increase the quality and quantity of the information obtained.
